skin in animals although a degree of itch occurs in some human cases.
The most common diseases of animals and man characterized by itch are those due to arthropod parasites. Fleas and lice give rise to transient irritation merely by their physical presence on the skin surface over which their movement causes sensation. While the occasional bite from such parasites is of little consequence in the nonsensitized individual, more serious effects are noted where a true sensitivity response occurs in both animals and man, resulting in lesions of papular urticaria through to blister formation.
Similar manifestations of arthropod infestation are attributable to surface living mites, e.g. Cheyletiella parasitovorax, Trombicula autumnalis or epidermal mites of the species Sarcoptes, all being accompanied by pruritus. A recent survey of those persons at risk to infestation with either Sarcoptes scabiei from dogs or Cheyletiella parasitovorax from dogs or cats has shown that more than 75 % of these individuals show evidence of pruritic skin disease contracted from infested animals in contact with them. The predilection sites for lesions in man are the arms and torso.
There is reason to believe that many cases of pruritic disease of animals transmitted to man do not come to diagnosis or may go undiagnosed and so it is reasonable to conclude that the incidence of these diseases is higher than at present supposed. Furthermore, there are, increasingly, reports of the isolation of Brucella from wild animals and from blood-sucking insects, especially ticks (reviewed by Morgan 1964) .
In Britain, brucellosis occurs chiefly in cattle and is caused by biotypes of B. abortus, more often biotypes 1, 2, 3, 4, 5 and 9. Brucellosis due to B. melitensis or by B. suis does not occur in this country and, as far as is known, there is no reservoir of disease in wild animals.
Apart from laboratory infections, human brucellosis arises from contact, direct or indirect, with infected animals or their products. In countries where animal brucellosis has been eradicated, there has been an accompanying drop in the incidence of human brucellosis, e.g. in the USA the number of human cases has been reduced from 6,321 in 1947 to 248 in 1967; it is significant that half of these cases were attributable to swine as the probable source of infection. Similarly, no human case of brucellosis has been recorded from Finland for many years; however, Ahvonen & Jansson (1968) , investigating human sera with high levels of brucella agglutinating antibody found that such sera also agglutinated to high titre Yersinia enterolitica type 9 antigen but not antigens prepared from other types of Yersinia enterolitica or from Y. pseudotuberculosis. By cross-absorption experiments, it was concluded that the infective agent was Y. enterolitica and not B. abortus.
Therefore the control and eradication of animal brucellosis is closely linked with the elimination of the disease in man.
Bovine brucellosis presents a number of circumstances which affect diagnosis. The disease is one with often a long incubation period, varying from around six weeks to six to eight months or even more. This incubation period is often tied up with the stage of pregnancy at time of exposure, e.g. animals infected when non-pregnant or in the first trimester of pregnancy have a longer incubation period than those infected in the third trimester. During this incubation period, routine diagnostic tests may be negative although animals may well abort soon afterwards. This is why no reliance can be placed on the result of a single test. Experience in other countries has shown that, in heavily infected herds, it may be more economical to slaughter the whole herd than to rely on a prolonged and often unsuccessful period of testing and slaughter.
Abortion is the most notable clinical feature of the diseaseand this only in its initial, acute form.
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Most infected cows abort only once although the placenta may often be heavily infected at subsequent, apparently normal, calvings. The disease then enters its chronic carrier stageclinically symptomless but with the organism harboured intracellularlyoften in the supramammary lymph nodes and udder, with excretion in milk. This chronic stage may well be accompanied by a waning titre to the agglutination testoften below or around the diagnostic titre.
The use of Strain 19 vaccine for the control of contagious abortion leads to the production of antibodies whose persistence depends, mainly, on the age of the animals at the time of vaccination. For a policy of eradication, based on test and slaughter coupled with control by vaccination, to bc successful, there must be rigid control on the age at which Strain 19 vaccination is allowed. This period of controlled vaccination should last for some years before compulsory eradication is started.
Lastly, the disease is very contagious and, although the most common method of spread is by the purchase of an infected animal, it may be spread from an infected to a clean farm across stock-proof fences by dragging of infected placentas or foetuses by wild animals and dogs.
There have been considerable advances made in the lastVfew years in the study of immunoglobulins, thelr structure, factors affecting their production and persistence. As with other bacterial diseases, the antibody response to brucellosis, either infection or Strain 19 vaccination, consists of an initial 1gM production followed by IgG. After calfhood vaccination with Strain 19, the IgG disappears at about six months after vaccination whilst IgM may persist for very much longer. In the case of infection, however, the IgG antibodies persist at higher levels for much longer. In the longstanding, chronic carrier case, although the levels of antibodies detected by the routine agglutination test may be just at or well below the diagnostic level, these antibodies consist entirely of IgG.
In animal brucellosis, both IgM and IgG are able to fix complement although it appears that the IgG are much more 'effective' in doing so.
The sequel of production of immunoglobulins and differences in their properties are the basis of many of the so-called 'supplemental' diagnostic tests for animal brucellosis: complement-fixation test, heat inactivation, acid plate agglutination, mercaptoethanol and Rivanol (2-ethoxy-6, 9 diaminoacridine lactate) tests. All these tests are designed to detect the presence of IgG and are most useful in the chronic stage of the disease.
More recently a 'card' test designed for both cattle and swine brucellosis has been developed in the USA (Nicoletti 1967) . The antigen consists of brucella cells stained with rose bengal and suspended in buffered saline at pH 3 5. It is claimed that by the use of this antigen it is possible to detect infected animals at an earlier stage than with other tests. If this were confirmed, the test would obviously be of considerable value for the control of the disease in that infected animals could be removed from the herd at an earlier stage and so reduce the chance of spread. At this laboratory, rose bengal antigen has been used on sera alongside the agglutination and complement-fixation tests using the criteria laid down for the Brucellosis (Accredited Herds) Scheme (Veterinary Record 1967). The results are summarized in Table 1 . With few exceptions (017%) the plate test is positive when the CF test is positive and, within limits, irrespective of the agglutination titre: e.g. some sera with 100 i.u. to the SAT, but negative to the CF test, are negative to the RBA plate test; but sera with 100 i.u. to the agglutination test and positive to the CF test are also positive to the plate test. Furthermore, the RBA plate test is positive when the agglutination test is 'negative' although the CF test is positive. The test, therefore, shows considerable promise as a selective diagnostic test, easier to perform than combined SAT and CFTs, and useful for differentiating infection from vaccination.
Experience has shown that vaccination by itself will not eradicate brucellosis from the national herd. The immunity produced by Strain 19, as with other brucella vaccines, is not absolute and can be broken down by increasing the level of infection (Manthei 1960 , McDiarmid 1960 . The degree of protection can be reduced from around 70 % to 50 % by a tenfold increase in the challenge dose. It is obvious, therefore, that a policy of vaccination is more likely to succeed if combined with measures of husbandry designed to reduce the amount and extent of exposure. The period of greatest danger is at and immediately after abortion or an apparently normal but infective calving. Spread can be considerably controlled by allowing the calvings to take place in isolation.
For reasons stated earlier, the use of Strain 19 vaccine is now confined to female calves between 91 and 180 days of age. For vaccinations outside this age range, under certain circumstances, 45/20 adjuvant vaccine may be used. It is now generally agreed that this vaccine is not completely nonagglutinogenic; its agglutinogenicity depends on the previous brucella status of the animal, method of growing the bacterial cells and on the nature of the adjuvant (Morgan & McDiarmid 1968) . When used in animals that have been vaccinated in calfhood with Strain 19, 45/20 adjuvant vaccine causes a small increase in the agglutination titre which recedes in most cases to its pre-45/20-vaccination level. However, the CF titres tend to persist longer with a proportion of animals retaining CF titres at the inconclusive or low positive range. The height and persistence of the SAT titre depend to a large extent on the titre (if any) just before the use of the adjuvant vaccine; it is therefore advisable to blood-test animals before they are vaccinatedfirst, to detect and segregate obviously infected animals and, secondly, to obtain a 'baseline' for help in interpreting the results of future tests. Testing and segregating reactors and protecting by vaccination those animals at risk is more likely to succeed than either practice alone.
